Opioid Preparedness: Disruptions in Access to Controlled Substance Medications

ASTHO, with support and collaboration from CDC’s Opioid Rapid Response Program (ORRP), helps its members by conducting scenario-based preparedness exercises with health agency staff and diverse partners to support planning for and responding to disruptions in access to prescribed controlled substance medications, including but not limited to opioids, medications for opioid use disorder (MOUD), benzodiazepines, and other prescribed medications that require continuity of care.

What are Disruptions?

Overdoses involving prescription opioids, heroin, and synthetic opioids have increased nearly sixfold since 1999. In 2020, the United States saw the greatest number of overdose deaths ever recorded as the social and economic conditions associated with the COVID-19 pandemic converged.

A disruption is any event that halts the ability of a patient to access prescribed controlled substance medications or MOUD, including a provider’s death or retirement or a regulatory/licensing action against a prescriber. or MOUD, including a provider’s death or retirement or a regulatory/licensing action against a prescriber. These events can be especially dangerous for displaced patients, who face increased risk of negative physical and mental health effects including feelings of abandonment, depression, and symptoms of withdrawal. In the absence of continued care, patients experiencing untreated pain or withdrawal may turn to the illicit drug market, putting them at increased risk for overdose. Furthermore, with the changing landscape in the illicit market, disruptions have become a more urgent; pressing issues such as fentanyl and counterfeit prescription pills have created a more deadly supply. 

What is the Opioid Rapid Response Program?

The Opioid Rapid Response Program (ORRP) is an interagency, coordinated federal effort to help mitigate overdose risks and support continuity of care among patients who lose access to a prescriber of opioids, MOUD, or other controlled substances (e.g., benzodiazepines). ORRP is managed by the Centers for Disease Control and Prevention (CDC) in partnership with the US Department of Health and Human Services Office of Inspector General (HHS OIG).

Opioid Preparedness Exercises

ASTHO’s preparedness tabletop exercises will aim to provide information and build knowledge about opioid closure events, facilitate important planning discussions among key state agencies and organizations, and provide a structure for developing and/or refining a written response protocol. These exercises are based on the Homeland Security Exercise and Evaluation Program (HSEEP) tabletop exercise model—a discussion-based scenario that facilitates conceptual understanding, identifies strengths and areas for improvement, and/or achieves changes in perceptions about plans, policies, or procedures.

The time commitment is two hours per session, for a total of four hours.

Exercise participants have included state and local health department and behavioral health agency staff, peer recovery specialists, first responders, physicians, linkage-to-care coordinators, drug overdose prevention specialists, hospital systems, private payers and Medicaid, primary care associations, and community health center associations, among others.

Opioid Preparedness Resources

Exercise Summary

Decorative.

The summary document provides an overview of ASTHO’s opioid preparedness exercise and outlines what participants can expect when attending a session.

Review the Summary (PDF)

Guidebook

Decorative.

The guidebook focuses on how state health agencies can prepare for and respond to disruptions in patient access to prescribed controlled substance medications. This resource also explores why disruptions occur and the possible risks to patients, how state response plans may look, and includes helpful information and examples that support state protocol development.

Review the Guidebook

Response Protocol Template

Decorative.

This is a template for states to adapt and reference when developing a protocol for planning for and responding to disruptions in access to opioid and other controlled substance prescriptions due to a law enforcement action against a health care provider.

Access the Template (PDF)

Opioid Preparedness Exercise in a Box

Decorative.

This module houses all the materials that a state or territory would need to plan and facilitate an exercise to develop, test, and/or enhance a state response protocol for responding to disruptions in access to prescribed controlled substance medications. 

Access the Materials

Trusted Contacts Training Modules

Trusted Contacts Training Module 1 slide deck cover

Three on-demand training modules detail what it means to be a state trusted contact for CDC’s Opioid Rapid Response Program and provide essential background for state trusted contacts to better prepare for and respond to disruptions in access to prescribed controlled substance medications. 

Take the Training

Reduce Stigma to Improve Care for Patients Taking Long-Term Opioid Therapy

Long-term opioid therapy (LTOT) is often prescribed for chronic pain when other options have failed. However, due to the history of widespread opioid overprescription and the current overdose crisis, LTOT is associated with negative perceptions. This stigma poses a barrier to care continuity for these patients, which is particularly concerning, as abruptly discontinuing such medication can lead to adverse health effects due to physical dependency. These resources assist health care workers and state health departments in addressing and mitigating stigma affecting patients on LTOT.

How Health Care Providers Can Reduce Stigma

Decorataive.

This report aims to increase awareness among health care providers about the stigma surrounding LTOT and emphasizes the importance of addressing it to ensure proper care for individuals dependent on these medications.

Access the Health Care Providers Report

How State Health Departments Can Reduce Stigma

Decorative.

This resource aims to assist state and territorial health departments in mitigating stigma affecting patients already on LTOT for chronic pain, emphasizing the importance of care continuity to prevent serious health risks associated with abrupt medication discontinuation.

Access the State Health Departments Report

Learning Community Sessions

Session 1: Risk Assessment

Session 2: Risk Mitigation Strategies

Session 3: Continuity of Care

Session 4: Building Partnerships

Opioid Preparedness Technical Assistance and Exercises

ASTHO provides hands-on technical assistance to support state and territorial health agencies in planning, testing, and enhancing rapid response systems overdose-related events, including controlled substance disruptions, emerging drug threats, and overdose spikes. Assistance is designed to strengthen jurisdictional readiness, coordination, and continuity of care when patients experience abrupt disruptions in access to regulated medications.

Our support offerings include:

  • Customized preparedness planning and protocol review – applying the Opioid Preparedness framework to strengthen or refine response structures, roles, and communication pathways.
  • Facilitated exercises and workshops – supporting partners in exploring coordination, communication, and continuity of care strategies during disruptions in access to controlled substance medications.
  • Peer matching and shared learning – connecting jurisdictions facing similar challenges to exchange lessons learned, templates, and practical tools.
  • Resource and tool development – providing access to planning templates, facilitation guides, and state examples to inform and strengthen preparedness approaches.

All assistance is fully customizable and designed to align with each jurisdiction’s priorities, organizational structure, and current stage of preparedness.

Contact the team to learn more or request tailored support. 

Contact the Team

For more information, contact ASTHO's Opioid Preparedness Team at opioidpreparedness@astho.org.

The development of this product is supported by the Center for State, for State, Tribal, Local, and Territorial Support (CSTLTS) at the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) through the cooperative agreement CDC-RFA-OT18-1802.